Actual Medicinal Product (AMP) Pentoxifylline 400mg modified-release tablets (Dowelhurst Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Protect from light and store in well-closed, light-resistant containers.
- Provenance
-
Compatibility recommendation derived from Trental 400 modified-release tablets (Sanofi).
- Generic
- Pentoxifylline
- Formulation
- Pentoxifylline 400mg modified-release tablets
-
Pentoxifylline
-
Pentoxifylline 400mg modified-release tablets
-
Pentoxifylline 400mg modified-release tablets (Dowelhurst Ltd)
-
-